Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 23219286

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2013 Mar 9
First author
Davies C

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2013 Mar 9;381(9869):804
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    Lancet. 2013 Mar 9;381(9869):782-3. doi: 10.1016/S0140-6736(12)62038-8.
    note
    Source null
    related pmid
    23219287
    relationship
    Comment in
  3. citation
    Lancet. 2017 May 13;389(10082):1884. doi: 10.1016/S0140-6736(17)31004-8.
    note
    Source null
    related pmid
    28457627
    relationship
    Erratum in
  4. citation
    Lancet. 2017 May 13;389(10082):1884. doi: 10.1016/S0140-6736(17)31003-6.
    note
    Source null
    related pmid
    28457628
    relationship
    Comment in
  5. citation
    JAMA Oncol. 2018 Jan 1;4(1):15-16. doi: 10.1001/jamaoncol.2017.3510.
    note
    Source null
    related pmid
    29145574
    relationship
    Comment in

Authors and identifiers

  1. name
    Davies C
    type
    Author
  2. name
    Pan H
    type
    Author
  3. name
    Godwin J
    type
    Author
  4. name
    Gray R
    type
    Author
  5. name
    Arriagada R
    type
    Author
  6. name
    Raina V
    type
    Author
  7. name
    Abraham M
    type
    Author
  8. name
    Medeiros Alencar VH
    type
    Author
  9. name
    Badran A
    type
    Author
  10. name
    Bonfill X
    type
    Author
  11. name
    Bradbury J
    type
    Author
  12. name
    Clarke M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Davies C
    type
    Author
  2. name
    Pan H
    type
    Author
  3. name
    Godwin J
    type
    Author
  4. name
    Gray R
    type
    Author
  5. name
    Arriagada R
    type
    Author
  6. name
    Raina V
    type
    Author
  7. name
    Abraham M
    type
    Author
  8. name
    Medeiros Alencar VH
    type
    Author
  9. name
    Badran A
    type
    Author
  10. name
    Bonfill X
    type
    Author
  11. name
    Bradbury J
    type
    Author
  12. name
    Clarke M
    type
    Author
bibliography ids
  1. nci-bib-677c7d4b53276a7c7b1c1ff6
book metadata
content sha256
d10d026fc033a0fb37d788464cf120ca797bf597402c8b446ff6f68c44341c50
document type
citation
dois
  1. 10.1016/S0140-6736(12)61963-1
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:23219286
immutable id
pubmed:23219286@d10d026fc033a0fb37d788464cf120ca797bf597402c8b446ff6f68c44341c50
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
9869
name
Lancet (London, England)
nlm unique id
2985213R
pages
805-16
volume
381
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2013 Mar 9;381(9869):804
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    Lancet. 2013 Mar 9;381(9869):782-3. doi: 10.1016/S0140-6736(12)62038-8.
    note
    Source null
    related pmid
    23219287
    relationship
    Comment in
  3. citation
    Lancet. 2017 May 13;389(10082):1884. doi: 10.1016/S0140-6736(17)31004-8.
    note
    Source null
    related pmid
    28457627
    relationship
    Erratum in
  4. citation
    Lancet. 2017 May 13;389(10082):1884. doi: 10.1016/S0140-6736(17)31003-6.
    note
    Source null
    related pmid
    28457628
    relationship
    Comment in
  5. citation
    JAMA Oncol. 2018 Jan 1;4(1):15-16. doi: 10.1001/jamaoncol.2017.3510.
    note
    Source null
    related pmid
    29145574
    relationship
    Comment in
outcomes validated
false
pmid
23219286
provenance
batch id
99e85dbb34a1a3011c9a
provider
NCBI PubMed ESummary
record sha256
55d6c10759c8cb37d780e9e3be2ddd93f3852be47e4c46a2710738944873bf2f
response sha256
1f4a46dcee9da36f8f58fe356dce3f44a1b3004f404e9fb0184f4e08aed4acf2
retrieved at
2026-09-09T23:46:52.860383+00:00
publication date
display
2013 Mar 9
precision
day
year
2013
publication types
  1. Comparative Study
  2. Journal Article
  3. Randomized Controlled Trial
  4. Research Support, Non-U.S. Gov't
  5. Research Support, U.S. Gov't, Non-P.H.S.
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/23219286/
title
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.

Preserved source evidence · Not medical advice